Skip to main content
. 2025 Sep 16;32(9):515. doi: 10.3390/curroncol32090515
ccRCC clear cell renal carcinoma
DCO death certificate only
IQ-range interquartile range (Q1–Q3)
mRCC metastatic renal cell carcinoma
NET neuroendocrine tumor
Non-ccRCC non-clear cell renal carcinoma
RCC renal cell carcinoma
RER relative excess risk
TKI tyrosine kinase inhibitor
UISS University of California Los Angeles integrated staging system